In vivo efficacy of folate-targeted lipid–protamine–DNA (LPD-PEG-Folate) complexes in an immunocompetent syngeneic model for breast adenocarcinoma
- 12 December 2003
- journal article
- research article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 11 (2) , 128-134
- https://doi.org/10.1038/sj.cgt.7700662
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Codelivery of NF-κB Decoy-Related Oligodeoxynucleotide Improves LPD-Mediated Systemic Gene TransferMolecular Therapy, 2002
- Tumor Regression by Targeted Gene Delivery to the NeovasculatureScience, 2002
- Optimizing Prostate Cancer Suicide Gene Therapy Using Herpes Simplex Virus Thymidine Kinase Active Site VariantsHuman Gene Therapy, 2002
- Efficacy of herpes simplex virus thymidine kinase in combination with cytokine gene therapy in an experimental metastatic breast cancer modelCancer Gene Therapy, 2000
- In VivoLiver-Directed Gene Transfer in Rats and Pigs with Large Anionic Multilamellar Liposomes: Routes of Administration and Effects of Surgical Manipulations on Transfection EfficiencyJournal of Drug Targeting, 2000
- Similar Efficiency of DNA-Liposome Complexes and Retrovirus-Producing Cells for HSV-tkSuicide Gene Therapy of Peritoneal CarcinomatosisJournal of Drug Targeting, 2000
- Characterization of cationic lipid-protamine–DNA (LPD) complexes for intravenous gene deliveryGene Therapy, 1998
- Protamine sulfate enhances lipid-mediated gene transferGene Therapy, 1997
- Inhibition of Tumor Growth by Direct Intratumoral Gene Transfer of Herpes Simplex Virus Thymidine Kinase Gene with DNA–Liposome ComplexesHuman Gene Therapy, 1996
- Post-formation fluorescent labelling of liposomal membranes: In vivo detection, localisation and kineticsJournal of Immunological Methods, 1992